Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 13, 2014 12:25 ET | Source: Real Endpoints

Move Over Gilead? AbbVie Could Bring Serious Competition to HCV Market

WESTPORT, CT--(Marketwired - Oct 13, 2014) - Gilead's Harvoni (sofosbuvir/ledipasvir combination) is the top overall scorer, according to RxScorecard, a drug-value assessment tool from Real...
January 15, 2014 08:14 ET | Source: Reimbursement Intelligence

Reimbursement Intelligence Announces a Series of Major Key Strategic and Organization Changes

MADISON, NJ--(Marketwired - Jan 15, 2014) - Reimbursement Intelligence (RI), an information and marketing services firm that provides expert insights and solutions about the changing healthcare...
March 30, 2012 11:32 ET | Source: Value & Innovation

Cancer Drug Costs Unsustainable, According to Value & Innovation Webinar

WESTPORT, CT--(Marketwire - Mar 30, 2012) - The current economic model for treating cancer is badly broken, according to senior executives from healthcare insurance companies who discussed the...
November 29, 2011 10:07 ET | Source: Real Endpoints

Real Endpoints Launches New Reimbursement-Focused Information Service

WESTPORT, CT--(Marketwire - Nov 29, 2011) - Real Endpoints LLC, a new information company focused on healthcare reimbursement, announced today the launch of its Value & Innovation LLC...